BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
2,291 1% Last mo
MPM Capital, Prolog Ventures
Use BioMarin Pharmaceutical's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use BioMarin Pharmaceutical's historical monthly uniques as a proxy for mindshare and web traction.
Use BioMarin Pharmaceutical's historical Facebook likes and mentions to better understand their social media traction over time.
Use BioMarin Pharmaceutical's historical Linkedin followers to better understand their social media traction over time.
Use BioMarin Pharmaceutical's mobile downloads and app ranks to evaluate the performance of their mobile apps.
BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at WORLDSymposium™ 2018
BioMarin Pharmaceutical Inc BMRN Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15112017 Prices from USD $250
BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York
Popular Science Names BioMarin's Brineura® (cerliponase alfa) One of the Top Health Innovations of 2017 with "Best of What's New" Award
BioMarin Pharmaceutical Inc. Strategy SWOT and Corporate Finance Report Report Updated 02082017 Prices from USD $175